Reata Pharmaceuticals Profit Margin 2015-2021 | RETA
Current and historical gross margin, operating margin and net profit margin for Reata Pharmaceuticals (RETA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Reata Pharmaceuticals net profit margin as of September 30, 2021 is -2020.49%.
|Reata Pharmaceuticals Annual Profit Margins
|Reata Pharmaceuticals Quarterly Profit Margins
||Medical - Biomedical and Genetics
Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is engaged in identifying, developing and commercializing product candidates which modulate the activity of regulatory proteins involved in the biology of mitochondrial function, oxidative stress and inflammation to address the unmet medical needs of serious or life-threatening diseases. Reata Pharmaceuticals, Inc. is based in Irving, United States.